These findings were supported by an in-silico analysis of publicly available gene expression data derived from primary NB tumors, demonstrating the increased expression of genes involved in ribosomal biogenesis and the low expression of genes involved in NOTCH receptor processing and signaling in MYCN-amplified tumors when compared to non-MYCN-amplified tumors. Here, MYCN is linked to neuroblastoma.